# Nuclide record nct03690388 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct03690388/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct03690388", "NCT03690388" ;
  schema:name "A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Va"@en ;
  schema:description "A phase 3 trial of Cabozantinib in thyroid cancer, run by Exelixis, active and no longer recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct03690388/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03690388> ;
  nuclide:status "active" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/thyroid/> ;
  nuclide:drugs <https://nuclide.cc/drugs/cabozantinib/> .